Intec Pharma Ltd.
DelistedCIK 1638381fmd_08QXZ83ZSD8ZXATRWWQZPBQFQ7Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Mar 31, 2021, 17 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | 5 | 11 | 24 | 35 | 27 | 7 |
| Selling, general and administrative | 3 | 3 | 5 | – | – | – |
| Operating income | (8) | (14) | (29) | (43) | (47) | (14) |
| Interest expense | 0 | 0 | 0 | – | – | – |
| Income before taxes | (7) | (13) | (29) | (43) | (47) | (14) |
| Income tax expense | – | – | 0 | 0 | 1 | 0 |
| Net income from continuing operations | – | – | (29) | (44) | (48) | (14) |
| Net income | (7) | (13) | (29) | (44) | (48) | (14) |